Related Experiment Video
Updated: Jun 22, 2026

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Expression and functional roles of Smad1 and BMPR-IB in glioma development
Shuang Liu1, Zengmin Tian, Feng Yin
1Department of Brain Protection and Plasticity Research, Beijing Institute of Basic Medical Sciences, Beijing, China.
Abstract:
Here we report the negative correlation of phosphorylation of Smad1 and BMPR-IB expression with the development of human glioma. Western blot analysis showed that expression of both phospho-Smad1/5/8 and BMPR-IB were decreased in malignant glioma tissues compared with normal brain tissues. Kaplan-Meier survival curves revealed that lower expression ratio of phospho-Smad1/5/8 to Smad1 expression significantly correlates with poor patient survival. Transient transfection of BMPR-IB activates Smad1 signaling and induces differentiation and apoptosis of U251 and U87 glioblastoma cells. The effects could be blocked by cotransfection of Smad6. These results might provide new molecular marker and target for glioma diagnosis and therapy.
Insights
Decreased BMPR-IB and phospho-Smad1/5/8 expression correlate with human glioma development and poor survival. Restoring BMPR-IB induces glioblastoma cell differentiation and apoptosis, suggesting therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Glioma is a complex brain tumor with limited treatment options.
- The bone morphogenetic protein (BMP) signaling pathway plays a role in cell differentiation and development.
- Smad proteins are key mediators in BMP signaling.
Purpose of the Study:
- To investigate the correlation between Smad1 phosphorylation, BMP receptor-IB (BMPR-IB) expression, and human glioma progression.
- To explore the therapeutic potential of BMPR-IB in glioblastoma treatment.
Main Methods:
- Western blot analysis to assess protein expression levels in glioma tissues and cell lines.
- Kaplan-Meier survival analysis to correlate protein expression with patient outcomes.
- Transient transfection experiments to study the functional effects of BMPR-IB and Smad6.
Main Results:
- Expression of phospho-Smad1/5/8 and BMPR-IB was significantly reduced in malignant glioma tissues compared to normal brain tissues.
- A lower ratio of phospho-Smad1/5/8 to Smad1 expression correlated with poorer patient survival.
- BMPR-IB transfection activated Smad1 signaling, inducing differentiation and apoptosis in U251 and U87 glioblastoma cells.
- The effects of BMPR-IB were antagonized by Smad6.
Conclusions:
- Reduced BMPR-IB expression and Smad1 phosphorylation are associated with glioma development and progression.
- BMPR-IB signaling holds potential as a therapeutic target for glioma.
- Smad6 may counteract BMPR-IB-mediated anti-glioma effects.
More Related Videos
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Hedgehog Signaling Pathway